Number of pages: 100 | Report Format: PDF | Published date: February 09, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
According to the deep-dive market assessment study by Growth Plus Reports, the global continuous renal replacement therapy market was valued at US$ 1.19 billion in 2021 and is expected to register a revenue CAGR of 7.4% to reach US$ 2.26 billion by 2030.
Continuous Renal Replacement Therapy Market Fundamentals
Continuous renal replacement therapy (CRRT) is a favored method for controlling the hemodynamic state of patients with acute renal damage. Patients with acute renal failure and comorbidities, such as abnormalities or multiple organ failure in their circulatory systems, such as edema and heart insufficiency, are treated using CRRT devices. Other risks associated with the usage of these devices include postoperative liver failure, fulminant hepatitis, severe acute pancreatitis, and multiple organ failure.
Continuous Renal Replacement Therapy Market Dynamics
The continuous renal replacement therapy (CRRT) market is expected to show significant revenue growth during the forecast period due to growing cases of acute kidney injury (AKI) and sepsis and the growing geriatric population. Additionally, technological advancements play a crucial role in market revenue growth due to rising research for developing advanced products with enhanced outcomes. Furthermore, the market is also driven by the multidisciplinary research aspect and the large clinical benefits of this integrated technology in CRRT. Moreover, the growing demand for CRRT due to growth in the patient pool further fuels the revenue growth of this market.
However, the high procedure cost of CRRT and complications related to CRRT are some of the restraints in the market that can have an adverse impact on the market revenue growth to a certain extent.
Continuous Renal Replacement Therapy Market Ecosystem
The global continuous renal replacement therapy market has been analyzed from four perspectives: product, modality, end-user, and region.
Continuous Renal Replacement Therapy Market by Product
Based on product, the global continuous renal replacement therapy market is segmented into systems and consumables.
The consumables segment dominates the market with the largest revenue share owing to their short working lives and high and consistent demand. The consumables segment is further sub-segmented into hemofiltration, line sets, dialysate, and accessories. The segment revenue growth is further driven by the high demand for consumables, large availability, affordable rates, and a wide range of applications. The system segment is estimated to illustrate a noticeable development during the projected timeframe. Technological developments, such as CRRT, high-volume permeability, and the incorporation of EMR connections, are expected to boost market expansion. Furthermore, the increasing launch of advanced equipment for consistent performance in CRRT treatments stimulates the expansion of this category, consequently increasing market sales.
Continuous Renal Replacement Therapy Market by Modality
Based on modality, the global continuous renal replacement therapy market is segmented into continuous venous hemofiltration, continuous venous hemodialysis, continuous venous hemodiafiltration, and slow continuous ultra-filtration.
The continuous venous hemofiltration segment leads the market with the largest revenue share owing to the growing prevalence of fluid overload cases. Furthermore, the advantages offered by this modality, such as improved diffusion technique by reducing solutes and flexibility during the continuous renal replacement procedure, contribute to market expansion. In addition, increasing dialysis procedures further drives market development.
Continuous Renal Replacement Therapy Market by End-user
The global continuous renal replacement therapy market has been segmented based on end-users into hospitals, specialty clinics, ambulatory surgical centers, and others.
The hospitals segment accounts for the majority revenue share of the market owing to the growing demand for CRRT and the large patient dynamic. Additionally, a high percentage of patient satisfaction and enhanced services support market expansion. In hospitals, CRRT is most commonly used to treat acute kidney injuries (AKI). CRRT is used more frequently in critically ill patients with AKI, as it allows for continuous, slow, and gentle removal of waste products from the blood. Technology advancements have led to more compact, portable, and user-friendly CRRT machines, which can be used in ICU and non-ICU settings. There is a growing trend towards individualized or patient-specific CRRT, where treatment parameters are tailored to each patient's specific needs. CRRT is being used in combination with other therapies, such as hemodialysis and peritoneal dialysis, to provide optimal treatment for patients with AKI. Overall, CRRT is an important and evolving therapy for treating AKI in hospital settings. Such trends are helping to improve patient outcomes and quality of care further.
Continuous Renal Replacement Therapy Market by Region
Geographically, the global continuous renal replacement therapy market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World.
North America dominates the global market owing to the massive base of the aged population and the rise in cases of chronic kidney diseases in the region. High demand for CRRT due to the continued approval of novel products with the incorporation of advanced technologies and interfaces encourages the revenue growth of this region’s market. Additionally, the presence of major market players and the high awareness of CVVT among the population further fuel the revenue growth of this regional market.
Europe accounts for the second-largest revenue share of the market due to the rapid adoption of technologically advanced products and the presence of a well-developed healthcare system.
Asia Pacific is the fastest-emerging region in the global continuous renal replacement therapy market, ascribed to developing healthcare infrastructure and advancing healthcare facilities. Moreover, the rising sepsis and kidney failure incidence are responsible for this regional market revenue growth. Additionally, growing government initiatives and awareness campaigns boost this regional market development.
The demand for CRRT is perpetually increasing in the Middle East & Africa markets. The prevalence of chronic kidney disease and acute kidney injury is on the rise in the Middle East & Africa region, driving demand for CRRT. The development of healthcare infrastructure, including the expansion of dialysis centers and the availability of specialized healthcare providers, has led to increased access to CRRT in the region. Government and non-government organizations have launched awareness campaigns to educate the public about kidney disease screening and treatment's importance, which has helped increase demand for CRRT. The growth of the middle-class population in the Middle East and Africa region has led to increased spending on health and wellness, including the demand for advanced renal replacement therapies, such as CRRT. The overall economic growth of the region has led to increased investment in healthcare infrastructure and the availability of cutting-edge medical technologies, such as CRRT. In conclusion, the demand for CRRT is growing in the region, driven by a combination of increasing incidence of kidney disease, growing healthcare infrastructure, increased public awareness, and economic growth.
Continuous Renal Replacement Therapy Market Competitive Landscape
The prominent players operating in the global continuous renal replacement therapy market are:
The global continuous renal replacement therapy market was valued at US$ 1.19 billion in 2021.
The global continuous renal replacement therapy market is estimated to be valued at US$ 2.26 billion by 2030.
The growing prevalence of CRRT, rising novel product approvals, and increasing demand for CRRT are a few revenue growth drivers of the global continuous renal replacement therapy market.
The global continuous renal replacement therapy market is expected to register revenue growth at a CAGR of 7.4% from 2022 to 2030.
The high cost of advanced treatments and the high complexity of CRRT procedures can be some of the major hurdles to the optimal revenue growth of this market.
*Insights on financial performance are subject to the availability of information in the public domain